Category: Abbott Laboratories
Abbott's 1st-quarter profits top expectations as sales of its branded generic drugs jump.
Here's a look at some of the top regulatory stories for medical device companies this week: Abbott unveils over-the-counter glucose meter; Medtronic's Micra leadless pacemaker wins EU approval; FDA clears Conventus PH shoulder cage; FDA approves AcuFocus Kamra inlay; Cardiac Assist wins CE Mark for emergency cannula
Abbott Laboratories receives FDA approval for a new, budget-priced glucose monitor that can be purchased without a prescription.
Abbott (NYSE:ABT) said it received FDA approval for a new, budget-priced glucose monitor that can be purchased without a prescription.
Here's a look at some of the top legal news stories for medical device companies this week: Baxter drops FloSeal case against J&J; Feds: We got $119m in fraud penalties from medtech companies last year; Insurer, DJO Global settle pain pump suit
, Boston Scientific
, CareFusion Corp.
, Dept. of Health & Human Services (HHS)
, Dept. of Justice (DOJ)
, DJO Global
, Ethicon Inc.
, Ironshore Specialty Insurance
, Johnson & Johnson
, Omni Surgical/Spine360
, Smith & Nephew
, Abbott Laboratories
, Genzyme Corp.
The U.S. Health & Human Services Dept. and the Justice Dept. say they collected some $119 million in healthcare fraud penalties from medical device companies during fiscal 2014.
India approves Abbott's FreeStyle Libre Pro Flash system, featuring a patient-worn sensor that logs blood sugar levels for up to 14 days.
Regulators in India approved a glucose monitoring system made by Abbott (NYSE:ABT) that's designed to track patients' blood sugar levels for up to 2 weeks.
Ferolyn Powell, the former CEO of Evalve who led it to a $410 million acquisition by Abbott, is killed in a motorbike accident in Thailand.
Former Evalve CEO Ferolyn Powell, who led the MitraClip developer to a $410 million acquisition by Abbott (NYSE:ABT), died this month in a motorbike accident in northern Thailand, her family said yesterday.
, Cantel Medical Corp.
, Clayton Dubilier Rice
, InVivo Therapeutics Corp.
, JP Morgan Chase
, NxThera Inc.
, Spectranetics Corp.
, SurModics Inc.
, Urologix Inc.
, Abbott Laboratories